The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Innovative approaches for cancer treatment: current perspectives and new challenges
Open accessAbstract
Every year, cancer is responsible for millions of deaths worldwide and, even though much progress has been achieved in medicine, there are still many issues that must be addressed in order to improve cancer therapy.For this reason, oncological research is putting a lot of effort towards finding new and efficient therapies which can alleviate critical side effects caused by conventional treatments.Different technologies are currently under evaluation in clinical trials or have been already introduced into clinical practice.While nanomedicine is contributing to the development of biocompatible materials both for diagnostic and therapeutic purposes, bioengineering of extracellular vesicles and cells derived from patients has allowed designing ad hoc systems and univocal targeting strategies.In this review, we will provide an in-depth analysis of the most innovative advances in basic and applied cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Quantitative Imaging for Evaluation of Response to Cancer Therapy
Clarke, L. P., Croft, B. S., Nordstrom, R. J., Zhang, H., Kelloff, G. J., & Tatum, J. L. (2009) · Translational Oncology · doi:10.1593/tlo.09217 · Cited by 46
Kabary, D. M., Helmy, M. W., Abdelfattah, E.-Z. A., Fang, J., Elkhodairy, K. A., & Elzoghby, A. O. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.06.027 · Cited by 45
Urabe, F., Kosaka, N., Yoshioka, Y., Egawa, S., & Ochiya, T. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0176-z · Cited by 42
Solid Lipid Nanoparticles: A Promising Drug Delivery System
Singh, J., & Khare, S. (2022) · International Journal of Science and Research (IJSR) · doi:10.21275/sr22629133912 · Cited by 41
Gene therapy for high-grade glioma: Current approaches and future directions
Natsume, A., & Yoshida, J. (2008) · Cell Adhesion & Migration · doi:10.4161/cam.2.3.6278 · Cited by 38
Recent advances in siRNA delivery
Sarısözen, C., Salzano, G., & Torchilin, V. P. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2015-0019 · Cited by 38
Enhanced Anti-Tumor Effects with Microencapsulated c- myc Antisense Oligonucleotide
Putney, S. D., Brown, J. N., Cucco, C., Lee, R., Skórski, T., Leonetti, C., Geiser, T., Calabretta, B., Zupi, G., & Zon, G. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.451 · Cited by 36
Kim, E., & Jeong, H. (2016) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-016-0435-8 · Cited by 32
Biomembrane-permeable and Ribonuclease-resistant siRNA with Enhanced Activity
Liao, H., & Wang, J. H. (2005) · Oligonucleotides · doi:10.1089/oli.2005.15.196 · Cited by 31
Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic
Shanker, M., Jin, J., Branch, C. D., Miyamoto, S., Grimm, E. A., Roth, J. A., & Ramesh, R. (2011) · Journal of Drug Delivery · doi:10.1155/2011/465845 · Cited by 24
Inhibition of mTOR/S6K1/4E-BP1 Signaling by Nutraceutical SIRT1 Modulators
Bianchi, S. E., & Giovannini, L. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1446093 · Cited by 20
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
New approaches and procedures for cancer treatment: Current perspectives
Debela, D. T., Muzazu, S. G., Heraro, K. D., Ndalama, M. T., Mesele, B. W., Haile, D. C., Kitui, S. K., & Manyazewal, T. (2021) · SAGE Open Medicine · doi:10.1177/20503121211034366 · Cited by 1,597
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
Cancer treatment therapies: traditional to modern approaches to combat cancers
Kaur, R., Bhardwaj, A., & Gupta, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08809-3 · Cited by 561
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z.-S., Kumar, A., Vishakha, Behl, T., Jha, S. K., & Tang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01805-y · Cited by 554
Metadata
- Authors
- Pucci, C., Martinelli, C., & Ciofani, G.
- Venue
- ecancermedicalscience
- Publisher
- Ecancer Global Foundation
- Published
- 2019-09-10
- Volume
- 13
- Pages
- 961-961
- ISSN
- 1754-6605 (ISSN-L)
- OpenAlex
- W2972713173
- Cited by
- 814
- References
- 211
- FWCI
- 26.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.